Bupivacaine
NDC 57884-3251, Bupivacaine, injection, suspension, liposomal, from Jiangsu Hengrui Pharmaceuticals Co., Ltd..
- Product NDC
- 57884-3251
- Status
- Listed
- Labeler
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INFILTRATION
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214348
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57884-3251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPIVACAINE13.3 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57884-3251-1 | 57884325101 | 10 VIAL in 1 CARTON (57884-3251-1) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0af296bb-1599-4b35-b66b-994924d3e898
Use it
Look up 57884-3251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57884-3251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57884-3251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.